Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone.

Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone. J Clin Oncol. 1985 Sep; 3(9):1166-73.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.